Page last updated: 2024-10-24

busulfan and Hemorrhage

busulfan has been researched along with Hemorrhage in 49 studies

Hemorrhage: Bleeding or escape of blood from a vessel.

Research Excerpts

ExcerptRelevanceReference
"Therapeutic options for patients with polycythemia vera (PV) and essential thrombocythemia (ET) resistant or intolerant to hydroxyurea are limited."9.19Busulfan in patients with polycythemia vera or essential thrombocythemia refractory or intolerant to hydroxyurea. ( Alvarez-Larrán, A; Ancochea, A; Angona, A; Antelo, ML; Bellosillo, B; Besses, C; Burgaleta, C; Cervantes, F; Durán, MA; Ferrer-Marín, F; Gómez, M; Gómez-Casares, MT; Hernández-Boluda, JC; Marcote, B; Martínez-Avilés, L; Martínez-Trillos, A; Mata, MI; Senín, A; Vicente, V; Xicoy, B, 2014)
" From 1974 to 1986 we treated 20 symptomatic ET patients with microvascular circulation disturbances including erythromelalgia (N = 18), atypical or typical transient ischemic attacks (N = 6), or acute coronary ischemic syndrome (N = 3) with aspirin and one course of busulfan."9.09Normal life expectancy and thrombosis-free survival in aspirin treated essential thrombocythemia. ( Michiels, JJ, 1999)
"High dose cyclophosphamide and/or busulfan conditioning treatment of recipients of bone marrow transplants proved to be highly effective but associated with substantial and sometimes life threatening hemorrhagic cystitis."7.69Prevention of hemorrhagic cystitis following allogeneic bone marrow transplant preparative regimens with cyclophosphamide and busulfan: role of continuous bladder irrigation. ( Abella, E; Haas, GP; Karanes, C; Lum, LG; Momin, F; Sensenbrenner, LL; Turkeri, LN; Uberti, JP, 1995)
"We report a case of severe hemorrhagic cystitis induced by prolonged busulfan therapy."7.66Busulfan-induced hemorrhagic cystitis. ( Perlberg, S; Pode, D; Steiner, D, 1983)
"A case of a busulfan-induced hemorrhage cystitis is reported."7.66Busulfan-induced hemorrhagic cystitis. ( Millard, RJ, 1981)
"Therapeutic options for patients with polycythemia vera (PV) and essential thrombocythemia (ET) resistant or intolerant to hydroxyurea are limited."5.19Busulfan in patients with polycythemia vera or essential thrombocythemia refractory or intolerant to hydroxyurea. ( Alvarez-Larrán, A; Ancochea, A; Angona, A; Antelo, ML; Bellosillo, B; Besses, C; Burgaleta, C; Cervantes, F; Durán, MA; Ferrer-Marín, F; Gómez, M; Gómez-Casares, MT; Hernández-Boluda, JC; Marcote, B; Martínez-Avilés, L; Martínez-Trillos, A; Mata, MI; Senín, A; Vicente, V; Xicoy, B, 2014)
" From 1974 to 1986 we treated 20 symptomatic ET patients with microvascular circulation disturbances including erythromelalgia (N = 18), atypical or typical transient ischemic attacks (N = 6), or acute coronary ischemic syndrome (N = 3) with aspirin and one course of busulfan."5.09Normal life expectancy and thrombosis-free survival in aspirin treated essential thrombocythemia. ( Michiels, JJ, 1999)
"High dose cyclophosphamide and/or busulfan conditioning treatment of recipients of bone marrow transplants proved to be highly effective but associated with substantial and sometimes life threatening hemorrhagic cystitis."3.69Prevention of hemorrhagic cystitis following allogeneic bone marrow transplant preparative regimens with cyclophosphamide and busulfan: role of continuous bladder irrigation. ( Abella, E; Haas, GP; Karanes, C; Lum, LG; Momin, F; Sensenbrenner, LL; Turkeri, LN; Uberti, JP, 1995)
"We report a case of severe hemorrhagic cystitis induced by prolonged busulfan therapy."3.66Busulfan-induced hemorrhagic cystitis. ( Perlberg, S; Pode, D; Steiner, D, 1983)
"A case of a busulfan-induced hemorrhage cystitis is reported."3.66Busulfan-induced hemorrhagic cystitis. ( Millard, RJ, 1981)
"Erythromelalgia was localized in the forefoot sole and toes in 28, the fingertips in 9, the handpalm in 2."2.39Erythromelalgic, thrombotic and hemorrhagic manifestations in 50 cases of thrombocythemia. ( Lindemans, J; Michiels, JJ; van Genderen, PJ; van Vliet, HH, 1996)
"Aspirin (ASS) was the most frequently used drug in 47 of 93 recorded cases (51%)."2.39Essential thrombocythemia and pregnancy. ( Griesshammer, M; Heimpel, H; Pearson, TC, 1996)
"The risk of major thrombosis is higher in ET patients aged more than 60 ys."2.39Treatment strategies in essential thrombocythemia. A critical appraisal of various experiences in different centers. ( Barbui, T; Brière, J; Dupuy, E; Finazzi, G; Kiladjian, JJ, 1996)
"Risk of thrombosis is higher in JAK2-mutated ET."1.51Polycythemia vera and essential thrombocythemia: 2019 update on diagnosis, risk-stratification and management. ( Barbui, T; Tefferi, A, 2019)
"Busulfan treatment did not affect edema and hemorrhage in P-selectin- or PSGL-1-deficient mice, suggesting that the effect by busulfan is dependent on P-selectin and PSGL-1 expression."1.36Platelets control leukocyte recruitment in a murine model of cutaneous arthus reaction. ( Fujimoto, M; Hara, T; Hasegawa, M; Iwata, Y; Komura, K; Muroi, E; Ogawa, F; Sato, S; Shimizu, K; Takenaka, M; Yanaba, K, 2010)
"Mesna possibly has a toxic effect on bladder mucosa."1.32Multivariate analysis of risk factors for hemorrhagic cystitis after hematopoietic stem cell transplantation. ( Hattori, K; Hotta, T; Inoue, H; Kato, S; Kawada, H; Kishi, K; Matsumoto, M; Ogawa, Y; Ohmachi, K; Shimizu, T; Tsuboi, K; Watanabe, S; Yabe, H; Yabe, M; Yasuda, Y; Yoshiba, F, 2003)
"Haemorrhagic cystitis is a common and often debilitating complication of chemotherapy for which treatment is frequently unsatisfactory."1.30Hyperbaric oxygen in the treatment of refractory haemorrhagic cystitis. ( Hughes, AJ; Millar, IL; Schwarer, AP, 1998)
"Bleeding and thrombosis are frequent complications in myeloproliferative disorders (MPD) and are associated with severe organ damage and a high mortality."1.28Incidence and clinical risk factors for bleeding and thrombotic complications in myeloproliferative disorders. A retrospective analysis of 260 patients. ( Daum, I; Jamin, H; Schneider, W; Wehmeier, A, 1991)
"One characteristic of experimental allergic encephalomyelitis (EAE) in all species is the presence of a considerable leukocyte infiltrate in the central nervous system (CNS)."1.27Experimental allergic encephalomyelitis in the absence of a classical delayed-type hypersensitivity reaction. Severe paralytic disease correlates with the presence of interleukin 2 receptor-positive cells infiltrating the central nervous system. ( Brostoff, S; Mason, D; Sedgwick, J, 1987)
" Thus, we have developed a safe chemotherapy schedule for transplantation that avoids the need for radiotherapy and can, if necessary, be repeated after a 3-month interval."1.27Busulphan and cyclophosphamide cause little early toxicity during displacement bone marrow transplantation in fifty children. ( Barnes, R; Downie, CJ; Hobbs, JR; Hugh-Jones, K; Shaw, PJ, 1986)

Research

Studies (49)

TimeframeStudies, this research(%)All Research%
pre-199024 (48.98)18.7374
1990's15 (30.61)18.2507
2000's5 (10.20)29.6817
2010's4 (8.16)24.3611
2020's1 (2.04)2.80

Authors

AuthorsStudies
Santos Carreira, A1
Salas, MQ1
Remberger, M2
Novitzky-Basso, I1
Law, AD1
Lam, W1
Pasic, I1
Mazzulli, T1
Cserti-Gazdewich, C1
Kim, DDH1
Michelis, FV1
Viswabandya, A1
Gerbitz, A1
Lipton, JH1
Kumar, R1
Hassan, M2
Mattsson, J2
Törlen, J1
Serafi, IE1
Garming-Legert, K1
Björklund, A1
Ljungman, P1
Sundin, M1
Tefferi, A1
Barbui, T3
Alvarez-Larrán, A1
Martínez-Avilés, L1
Hernández-Boluda, JC1
Ferrer-Marín, F1
Antelo, ML1
Burgaleta, C1
Mata, MI1
Xicoy, B1
Martínez-Trillos, A1
Gómez-Casares, MT1
Durán, MA1
Marcote, B1
Ancochea, A1
Senín, A1
Angona, A1
Gómez, M1
Vicente, V1
Cervantes, F1
Bellosillo, B1
Besses, C1
Hara, T1
Shimizu, K1
Ogawa, F1
Yanaba, K1
Iwata, Y1
Muroi, E1
Takenaka, M1
Komura, K1
Hasegawa, M1
Fujimoto, M1
Sato, S1
WEBB, AT1
MEYER, FL1
LONSER, ER1
BRODY, JI1
MCKENZIE, D1
KIMBALL, SG1
MATSUOKA, M1
MOLANDER, DW1
LADUE, JS1
BANERJEA, JC1
MUKHERJEE, SK1
Tsuboi, K1
Kishi, K1
Ohmachi, K1
Yasuda, Y1
Shimizu, T1
Inoue, H1
Matsumoto, M1
Hattori, K1
Yoshiba, F1
Watanabe, S1
Ogawa, Y1
Kawada, H1
Yabe, H1
Yabe, M1
Kato, S1
Hotta, T1
Asano, Y1
Kanda, Y1
Ogawa, N1
Sakata-Yanagimoto, M1
Nakagawa, M1
Kawazu, M1
Goyama, S1
Kandabashi, K1
Izutsu, K1
Imai, Y1
Hangaishi, A1
Kurokawa, M1
Tsujino, S1
Ogawa, S1
Aoki, K1
Chiba, S1
Motokura, T1
Hirai, H1
Pode, D1
Perlberg, S1
Steiner, D1
Millard, RJ1
Turkeri, LN1
Lum, LG1
Uberti, JP1
Abella, E1
Momin, F1
Karanes, C1
Sensenbrenner, LL1
Haas, GP1
van Genderen, PJ2
Michiels, JJ3
Bernaudin, F1
Souillet, G1
Vannier, JP1
Plouvier, E1
Lemerle, S1
Michel, G1
Bordigoni, P1
Lutz, P1
Kuentz, M1
Erer, B1
Angelucci, E1
Baronciani, D1
Tomasucci, M1
Giardini, C1
Gaziev, J1
Lindemans, J1
van Vliet, HH1
Griesshammer, M1
Heimpel, H1
Pearson, TC1
Finazzi, G2
Dupuy, E1
Kiladjian, JJ1
Brière, J1
Hughes, AJ1
Schwarer, AP1
Millar, IL1
Randi, ML2
Rossi, C2
Fabris, F2
Menapace, L1
Girolami, A2
Zhu, K1
Xu, Y1
Wu, D1
Xu, X1
Huang, L1
Leung, AY1
Mak, R1
Lie, AK1
Yuen, KY1
Cheng, VC1
Liang, R1
Kwong, YL1
Whittaker, JA1
Khurshid, M1
Grossi, A1
Vannucchi, AM1
Longo, G1
Rafanelli, D1
Rossi Ferrini, P1
Romeiras, M1
Rodrigues, AS1
Machado, A1
Jorge, L1
Nolasco, I1
Abecasis, M1
Wehmeier, A1
Daum, I1
Jamin, H1
Schneider, W1
Atkinson, K2
Biggs, JC1
Golovsky, D1
Concannon, A2
Dodds, A2
Downs, K1
Ashby, M2
Cortelazzo, S1
Viero, P1
D'Emilio, A1
Rodeghiero, F1
Sedgwick, J1
Brostoff, S1
Mason, D1
Thomas, AE1
Patterson, J1
Prentice, HG1
Brenner, MK1
Ganczakowski, M1
Hancock, JF1
Pattinson, JK1
Blacklock, HA1
Hopewell, JP1
Shaw, PJ1
Hugh-Jones, K1
Hobbs, JR1
Downie, CJ1
Barnes, R1
Biggs, J1
Noble, G1
Tsygankova, VA1
Rudakov, IA1
Whitcomb, ME2
Bernadou, A1
Clauvel, JP1
Antebi, L1
Bilski-Pasquier, G1
Schwarz, MI1
Goldman, AL1
Rorvik, TO1
Rudowski, W1
Klawe, Z1
Woźniewska, M1
Ziemski, JM1
Jamshidi, K1
Ansari, A1
Windschitl, HE1
Swaim, WR1
Dunn, CD1
Elson, LA1
Ravich, RB1
Gunz, FW1
Thompson, IL1
Reed, CS1
Larbi, SO1
Philp, RB1
Gowdey, CW1
Levine, J1
Swanson, PD1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Mortality Due to Septic Shock Associated With Thrombocytopenia in the Intensive Care Unit[NCT03617965]350 participants (Anticipated)Observational2018-08-15Active, not recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

9 reviews available for busulfan and Hemorrhage

ArticleYear
Male predominance among Japanese adult patients with late-onset hemorrhagic cystitis after hematopoietic stem cell transplantation.
    Bone marrow transplantation, 2003, Volume: 32, Issue:12

    Topics: Adenoviridae Infections; Adenoviruses, Human; Adolescent; Adult; Aged; Anemia, Aplastic; BK Virus; B

2003
Primary thrombocythemia: diagnosis, clinical manifestations and management.
    Annals of hematology, 1993, Volume: 67, Issue:2

    Topics: Adolescent; Adult; Aged; Busulfan; Child; Diagnosis, Differential; Female; Hemorrhage; Humans; Hydro

1993
Erythromelalgic, thrombotic and hemorrhagic manifestations in 50 cases of thrombocythemia.
    Leukemia & lymphoma, 1996, Volume: 22 Suppl 1

    Topics: Adult; Aged; Aspirin; Busulfan; Double-Blind Method; Erythromelalgia; Female; Gangrene; Hemorrhage;

1996
Essential thrombocythemia and pregnancy.
    Leukemia & lymphoma, 1996, Volume: 22 Suppl 1

    Topics: Abnormalities, Drug-Induced; Abortion, Spontaneous; Aspirin; Busulfan; Combined Modality Therapy; Di

1996
Treatment strategies in essential thrombocythemia. A critical appraisal of various experiences in different centers.
    Leukemia & lymphoma, 1996, Volume: 22 Suppl 1

    Topics: Adult; Aged; Alkylating Agents; Anemia, Megaloblastic; Arrhythmias, Cardiac; Bone Marrow Diseases; B

1996
[Essential thrombocythemia: conventional therapy].
    Haematologica, 1991, Volume: 76 Suppl 3

    Topics: Adult; Antineoplastic Agents; Busulfan; Follow-Up Studies; Hemorrhage; Humans; Hydroxyurea; Immunolo

1991
[Methods of studying blood thrombocytopoietic activity (literature review)].
    Laboratornoe delo, 1972, Volume: 2

    Topics: Anemia; Animals; Blood Platelets; Blood Transfusion; Busulfan; Hemorrhage; Humans; Leukemia; Methods

1972
Drug-induced lung disease.
    Chest, 1973, Volume: 63, Issue:3

    Topics: Anti-Bacterial Agents; Anticoagulants; Antihypertensive Agents; Bleomycin; Busulfan; Chlorpropamide;

1973
The spectrum of diffuse pulmonary infiltration in malignant disease.
    Chest, 1973, Volume: 64, Issue:1

    Topics: Adenocarcinoma, Bronchiolo-Alveolar; Busulfan; Embolism, Fat; Hemorrhage; Hodgkin Disease; Humans; I

1973

Trials

5 trials available for busulfan and Hemorrhage

ArticleYear
Busulfan in patients with polycythemia vera or essential thrombocythemia refractory or intolerant to hydroxyurea.
    Annals of hematology, 2014, Volume: 93, Issue:12

    Topics: Aged; Aged, 80 and over; Alkylating Agents; Blood Cell Count; Busulfan; Comorbidity; Disease Progres

2014
Normal life expectancy and thrombosis-free survival in aspirin treated essential thrombocythemia.
    Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis, 1999, Volume: 5, Issue:1

    Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Aspirin; Busulfan; Coronary Disease; Dise

1999
Aspirin seems as effective as myelosuppressive agents in the prevention of rethrombosis in essential thrombocythemia.
    Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis, 1999, Volume: 5, Issue:2

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aspirin; Busulfan; Disease-Free Survival; Female; Hemorr

1999
Relative toxicity of two different conditioning regimens in patients undergoing allogeneic bone marrow transplantation.
    Bone marrow transplantation, 1991, Volume: 7 Suppl 2

    Topics: Adolescent; Adult; Bone Marrow Transplantation; Busulfan; Child; Child, Preschool; Cyclophosphamide;

1991
Bladder irrigation does not prevent haemorrhagic cystitis in bone marrow transplant recipients.
    Bone marrow transplantation, 1991, Volume: 7, Issue:5

    Topics: Adolescent; Adult; Bone Marrow Transplantation; Busulfan; Catheters, Indwelling; Cyclophosphamide; C

1991

Other Studies

35 other studies available for busulfan and Hemorrhage

ArticleYear
Interaction Between High-Dose Intravenous Busulfan and Post-Transplantation Cyclophosphamide on Hemorrhagic Cystitis After Allogeneic Hematopoietic Cell Transplantation.
    Transplantation and cellular therapy, 2023, Volume: 29, Issue:9

    Topics: Adult; Antilymphocyte Serum; Busulfan; Cyclophosphamide; Cyclosporine; Cystitis; Hematopoietic Stem

2023
Toxicological effects of fludarabine and treosulfan conditioning before allogeneic stem-cell transplantation.
    International journal of hematology, 2017, Volume: 106, Issue:4

    Topics: Adolescent; Adult; Aged; Allografts; Busulfan; Child; Child, Preschool; Cystitis; Female; Hematopoie

2017
Polycythemia vera and essential thrombocythemia: 2019 update on diagnosis, risk-stratification and management.
    American journal of hematology, 2019, Volume: 94, Issue:1

    Topics: Adult; Aspirin; Bone Marrow; Busulfan; Disease Management; Disease Progression; Hemorrhage; Humans;

2019
Platelets control leukocyte recruitment in a murine model of cutaneous arthus reaction.
    The American journal of pathology, 2010, Volume: 176, Issue:1

    Topics: Animals; Arthus Reaction; Blood Platelets; Busulfan; Cell Aggregation; Cell Count; Cell Movement; Ch

2010
Hemorrhagic thrombocythemia. Response to busulfan.
    Archives of internal medicine, 1963, Volume: 111

    Topics: Blood Platelets; Busulfan; Female; Hemorrhage; Humans; Postpartum Hemorrhage; Postpartum Period; Thr

1963
MYLERAN AS A THERAPEUTIC ADJUNCT IN GASTROINTESTINAL BLEEDING COMPLICATING MYELOPROLIFERATIVE DISORDERS.
    Gastroenterology, 1963, Volume: 45

    Topics: Anemia; Anemia, Hypochromic; Blood Platelet Disorders; Bone Marrow Diseases; Busulfan; Gastrointesti

1963
[IMPROVEMENT AND EXACERBATION IN LEUKEMIA].
    [Sogo rinsho] Clinic all-round, 1963, Volume: 12

    Topics: Aminocaproates; Aminocaproic Acid; Anemia; Antineoplastic Agents; Blood Transfusion; Busulfan; Centr

1963
CHRONIC LEUKEMIA.
    Geriatrics, 1964, Volume: 19

    Topics: Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Alkylating Agents; Anemia; Anemia, Hemolytic,

1964
HAEMOPERICARDIUM IN CHRONIC MYELOID LEUKAEMIA.
    Indian heart journal, 1964, Volume: 16

    Topics: Adolescent; Busulfan; Drug Therapy; Electrocardiography; Hemorrhage; Humans; India; Joint Diseases;

1964
[HEMORRHAGIC THROMBOCYTHEMIA AND THE "MYELOPROLIFERATIVE SYNDROME"].
    Nordisk medicin, 1964, Dec-03, Volume: 72

    Topics: Anemia; Anemia, Hypochromic; Blood Platelets; Busulfan; Gastrointestinal Hemorrhage; Hemorrhage; Hem

1964
Multivariate analysis of risk factors for hemorrhagic cystitis after hematopoietic stem cell transplantation.
    Bone marrow transplantation, 2003, Volume: 32, Issue:9

    Topics: Adolescent; Antilymphocyte Serum; Busulfan; Cyclophosphamide; Cystitis; Drug Synergism; Female; Hema

2003
Busulfan-induced hemorrhagic cystitis.
    The Journal of urology, 1983, Volume: 130, Issue:2

    Topics: Adult; Busulfan; Cystitis; Female; Hemorrhage; Humans; Leukemia, Myeloid; Time Factors; Urinary Blad

1983
Busulfan-induced hemorrhagic cystitis.
    Urology, 1981, Volume: 18, Issue:2

    Topics: Busulfan; Cystitis; Hemorrhage; Humans; Male; Middle Aged; Urinary Bladder Diseases

1981
Prevention of hemorrhagic cystitis following allogeneic bone marrow transplant preparative regimens with cyclophosphamide and busulfan: role of continuous bladder irrigation.
    The Journal of urology, 1995, Volume: 153, Issue:3 Pt 1

    Topics: Adolescent; Adult; Bone Marrow Transplantation; Busulfan; Cyclophosphamide; Cystitis; Female; Hemorr

1995
Bone marrow transplantation (BMT) in 14 children with severe sickle cell disease (SCD): the French experience. GEGMO.
    Bone marrow transplantation, 1993, Volume: 12 Suppl 1

    Topics: Adolescent; Africa; Anemia, Sickle Cell; Bone Marrow Purging; Bone Marrow Transplantation; Busulfan;

1993
Hemorrhagic cystitis after allogeneic bone marrow transplantation for thalassemia.
    Bone marrow transplantation, 1993, Volume: 12 Suppl 1

    Topics: Adolescent; Adult; Bone Marrow Purging; Bone Marrow Transplantation; Busulfan; Child; Child, Prescho

1993
Hyperbaric oxygen in the treatment of refractory haemorrhagic cystitis.
    Bone marrow transplantation, 1998, Volume: 22, Issue:6

    Topics: Adenoviruses, Human; Adult; Antineoplastic Agents, Alkylating; BK Virus; Busulfan; Cyclophosphamide;

1998
Essential thrombocythemia in young adults: major thrombotic complications and complications during pregnancy--a follow-up study in 68 patients.
    Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis, 2000, Volume: 6, Issue:1

    Topics: Acute Disease; Adult; Age Factors; Arteriosclerosis; Aspirin; Busulfan; Cohort Studies; Disease-Free

2000
[The toxicity of busulphan and cyclophosphamide as the preparative regimen for allogeneic peripheral blood stem cell transplantation].
    Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi, 2000, Volume: 21, Issue:8

    Topics: Acute Disease; Adult; Busulfan; Cyclophosphamide; Cystitis; Disease-Free Survival; Esophagitis; Fema

2000
Clinicopathological features and risk factors of clinically overt haemorrhagic cystitis complicating bone marrow transplantation.
    Bone marrow transplantation, 2002, Volume: 29, Issue:6

    Topics: Adenoviridae; Adenoviridae Infections; Adolescent; Adult; Aged; BK Virus; Bone Marrow Transplantatio

2002
Hypofibrinogenaemia as a cause of bleeding in chronic myeloid leukaemia.
    British medical journal, 1975, Mar-01, Volume: 1, Issue:5956

    Topics: Afibrinogenemia; Aged; Blood Cell Count; Bone Marrow Cells; Busulfan; Chronic Disease; Disseminated

1975
Incidence and clinical risk factors for bleeding and thrombotic complications in myeloproliferative disorders. A retrospective analysis of 260 patients.
    Annals of hematology, 1991, Volume: 63, Issue:2

    Topics: Bloodletting; Busulfan; Cause of Death; Hemorrhage; Humans; Incidence; Leukemia, Myelogenous, Chroni

1991
Incidence and risk factors for thrombotic complications in a historical cohort of 100 patients with essential thrombocythemia.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1990, Volume: 8, Issue:3

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Busulfan; Cohort Studies; Female; Follow-Up Studies; Hem

1990
Experimental allergic encephalomyelitis in the absence of a classical delayed-type hypersensitivity reaction. Severe paralytic disease correlates with the presence of interleukin 2 receptor-positive cells infiltrating the central nervous system.
    The Journal of experimental medicine, 1987, Apr-01, Volume: 165, Issue:4

    Topics: Animals; Busulfan; Cells, Cultured; Central Nervous System; Cerebral Hemorrhage; Chlorambucil; Encep

1987
Haemorrhagic cystitis in bone marrow transplantation patients: possible increased risk associated with prior busulphan therapy.
    Bone marrow transplantation, 1987, Volume: 1, Issue:4

    Topics: Adolescent; Adult; Bone Marrow Transplantation; Busulfan; Child; Child, Preschool; Cyclophosphamide;

1987
Busulphan and cyclophosphamide cause little early toxicity during displacement bone marrow transplantation in fifty children.
    Bone marrow transplantation, 1986, Volume: 1, Issue:2

    Topics: Adolescent; Bone Marrow; Bone Marrow Transplantation; Busulfan; Child; Child, Preschool; Cyclophosph

1986
Preparative regimens for marrow transplantation containing busulphan are associated with haemorrhagic cystitis and hepatic veno-occlusive disease but a short duration of leucopenia and little oro-pharyngeal mucositis.
    Bone marrow transplantation, 1987, Volume: 2, Issue:4

    Topics: Anemia, Aplastic; Bone Marrow Transplantation; Busulfan; Cystitis; Hemorrhage; Hepatic Veno-Occlusiv

1987
[Vaquez's diseas. Clinical and developmental study. Apropos of 144 cases].
    La semaine des hopitaux : organe fonde par l'Association d'enseignement medical des hopitaux de Paris, 1968, Jun-26, Volume: 44, Issue:31

    Topics: Adult; Arteriosclerosis; Arteritis; Blood Sedimentation; Busulfan; Child; Erythrocyte Count; Female;

1968
[Polycythemia vera].
    Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 1974, Nov-20, Volume: 94, Issue:32

    Topics: Busulfan; Chronic Disease; Diagnosis, Differential; Hemorrhage; Humans; Phosphorus Radioisotopes; Po

1974
Major surgery in patients with polycythaemia vera.
    Haematologia, 1974, Volume: 8, Issue:1-4

    Topics: Aged; Blood Platelets; Blood Transfusion, Autologous; Bloodletting; Busulfan; Erythrocyte Count; Fem

1974
Primary thrombocythemia.
    Geriatrics, 1973, Volume: 28, Issue:1

    Topics: Adult; Aged; Blood Coagulation Tests; Bone Marrow Examination; Busulfan; Follow-Up Studies; Gastroin

1973
Quantitative studies of haemopoietic spleen colonies in rats treated with cytotoxic chemicals.
    British journal of haematology, 1970, Volume: 19, Issue:6

    Topics: Animals; Bone Marrow; Bone Marrow Cells; Bone Marrow Transplantation; Busulfan; Chlorambucil; Female

1970
The dangers of surgery in uncontrolled haemorrhagic thrombocythaemia.
    The Medical journal of Australia, 1970, Apr-04, Volume: 1, Issue:14

    Topics: Aged; Blood Cell Count; Blood Platelets; Busulfan; Hemorrhage; Humans; Male; Middle Aged; Peptic Ulc

1970
The effects of alkoxyglycerols on haematopoiesis.
    Archives internationales de pharmacodynamie et de therapie, 1968, Volume: 173, Issue:1

    Topics: Anemia; Animals; Benzene; Blood Cell Count; Busulfan; Chlorambucil; Erythrocyte Count; Female; Hemat

1968
Idiopathic thrombocytosis. A treatable cause of transient ischemic attacks.
    Neurology, 1968, Volume: 18, Issue:7

    Topics: Adult; Blood Platelet Disorders; Busulfan; Female; Hemorrhage; Humans; Hyperplasia; Ischemic Attack,

1968